Johnson Matthey updates Honeywell deal timeline and financial terms

Johnson Matthey

On 22nd May 2025, Johnson Matthey Plc (LON:JMAT) and Honeywell International, Inc. announced an agreement to sell JM’s Catalyst Technologies business to Honeywell.

JM and Honeywell have agreed to extend the long stop date for satisfaction of the closing conditions from 21st February to 21st July 2026. In the event that the only remaining antitrust approval condition is not satisfied by the Long Stop Date, the Long Stop Date may be further extended to 21st August 2026, if certain conditions are met. JM and Honeywell expect to complete the Transaction by the end of August 2026.

In agreeing to extend the Long Stop Date, JM and Honeywell have also agreed to amend the financial terms of the Transaction to reflect CT’s business performance during 2025/26, which includes the deferral of key sustainable solutions licensing projects and reduced profitability from the supply of catalysts due to the challenging market environment.  Accordingly, JM has agreed to sell the CT business to Honeywell for an enterprise value of £1,325 million on a cash and debt-free basis.

Consequently, JM now expects to return c.£1,000 million of net sale proceeds to its shareholders following completion of the Transaction, comprising £800 million through a special dividend with share consolidation, and £200 million through an on-market share buyback programme.

Johnson Matthey continues to make good progress on the implementation of its new cash-focused business model and is on track to deliver 2025/26 performance in line with guidance. This includes group underlying operating profit growth at the higher end of a mid single digit percentage range¹, and positive free cash flow that is materially higher than last year².

Share on:

Latest Company News

Johnson Matthey updates Honeywell deal timeline and financial terms

Johnson Matthey Plc and Honeywell have agreed to extend the completion timeline for the Catalyst Technologies transaction to July 2026 and amend the financial terms. The revised enterprise value is £1.325 billion.

Johnson Matthey issues pre-close update and reclassifies Catalyst Technologies

Johnson Matthey has confirmed that Catalyst Technologies, following its agreed sale to Honeywell, will be reported as a discontinued operation for 2025/26. In its pre-close update for the half year to 30 September 2025, the group expects strong growth in underlying operating profit, supported by efficiency gains and robust trading in PGM Services.

Johnson Matthey appoints Richard Pike as Chief Financial Officer Designate

Johnson Matthey plc appoints Richard Pike as Chief Financial Officer Designate, effective immediately, ensuring a smooth transition before April 2025.

Johnson Matthey Plc hosting PGM Services seminar for investors and analysts today

Join Johnson Matthey plc (LON:JMAT) as they host a PGM Services seminar, revealing how PGM Services drive the net zero transition and unlock growth opportunities.

Johnson Matthey Plc to sell Medical Device Components business for $700 million

Johnson Matthey Plc (LON:JMAT) has signed an agreement to sell its Medical Device Components business to Montagu Private Equity for US$700 million (£550 million).

    Search

    Search